RP_C18
Twenty-two years on reverse-phase methods. If your purity number has no method attached, it is not a number.
85kreputation
300answers
51accepted
11questions
1·5·8badges g·s·b
88tags
Badges
CustodianSustained accurate contribution across two or more calendar years
Cold Chain10 accepted answers on storage, cold-chain or peptide-stability
Second Opinion25 answers on a question that already had an accepted answer
DeconvolutedAnswered 15 questions tagged mass-spec or lc-ms
ArchivistEdited 40 or more posts for accuracy
QuorumReached 5,000 reputation
Asked WellA question with a score of 10 or more
First AcceptFirst answer marked as accepted
Citation NeededTen answers carrying a published citation
EditorFirst post edit
CommentatorLeft 30 comments
AutobiographerCompleted a profile
Tag WranglerActive in 8 or more distinct tags
Sample SubmittedPosted an independent third-party test result
Top answers
147Does hydrolysis of dulaglutide at minus 20 °C show up as a loss of content or of purity?accepted · answered 18 Jan 2025120Is 4 mg weekly a defensible maintenance dose for survodutide?accepted · answered 9 Apr 2025105Is 10 mg/mL a sensible working concentration for tirzepatide, or should I go lower?accepted · answered 26 Mar 2025104What did the placebo arm of STEP 1 report for headache?accepted · answered 17 Dec 2024101How does cagrilintide behave on a C8 column compared to tirzepatide?answered 17 Jun 2024101Is there any published stability data for cagrilintide at room temperature?answered 8 May 202499How do I reconcile an area-per-cent purity with an impurity table?answered 23 Jul 202497What happens after a seizure notice in Singapore?accepted · answered 3 Mar 2025
Top questions
41Is TRIUMPH-1 a fair comparison of dulaglutide against its comparator arm?5 answers, accepted · asked 11 Sept 202436My a GLP-1 receptor agonist vial sat at 4 °C for twenty-eight days — is testing worth it before use?3 answers, accepted · asked 17 May 202530Does racemisation dominate for retatrutide held at 4 °C?5 answers · asked 9 May 202522What is the dead-space loss per draw with a 18G drawing needle at 1 mg/mL?0 answers · asked 16 Apr 202621What does the mechanism of liraglutide predict that SURMOUNT-4 did not test?0 answers · asked 6 Apr 202420If I reconstitute a 15 mg vial with 0.5 mL of phosphate-buffered diluent, what concentration do I end up with?5 answers, accepted · asked 19 Nov 202518What did the placebo arm of SURMOUNT-4 report for nausea?1 answer · asked 29 Nov 202517Why did two QYB lots of semaglutide differ on content assay?5 answers, accepted · asked 22 Jan 2026